Photosens

Photosens is a mixture of sulfonated aluminium phthalocyanines with various degrees of sulfonation.^[1] Developed in Russia.

It is a photosensitiser (activated by 675 nm red light) sometimes used in photodynamic therapy trials.^[2]^[3]

It has been tried on Age-related macular degeneration^[4]

References

^ http://www.photobiology.com/v1/nadezhda/default.htm "Clinical results of updating method of a photodynamic therapy with “Photosens” :use as transport protein human albumines and fractional injection."^{[unreliable source?]}
^ Apolikhin, Oleg I.; Chernishov, Igor V.; Sivkov, Andrey V.; Altunin, Denis V.; Kuzmin, Sergey G.; Vorozhtsov, Georgy N. (2007). "Adjuvant Photodynamic Therapy (PDT) with Photosensitizer Photosens for Superficial Bladder Cancer. Experimental investigations to treat prostate cancer by PDT with Photosens". Therapeutic Laser Applications and Laser-Tissue Interactions III. pp. 6632_64. doi:10.1364/ECBO.2007.6632_64. ISBN 978-0-8194-6776-8. INIST 19084033.
^ Sokolov, Victor V.; Chissov, Valery I.; Yakubovskaya, Raisa I.; Aristarkhova, E. I.; Filonenko, E. V.; Belous, T. A.; Vorozhtsov, Georgy N.; Zharkova, Natalia N.; Smirnov, V. V.; Zhitkova, Margarita B. (31 January 1996). Ehrenberg, Benjamin; Jori, Giulio; Moan, Johan (eds.). "Photodynamic therapy (PDT) of malignant tumors by photosensitzer photosens: results of 45 clinical cases". Proceedings of the SPIE. Photochemotherapy: Photodynamic Therapy and Other Modalities. 2625: 281–287. Bibcode:1996SPIE.2625..281S. doi:10.1117/12.230943. S2CID 72304555.
^ Avetisov, SE; Budzinskaia, MV; Kiseleva, TN; Kazarian, EE; Gurova, IV; Smirnova, TV; Shchegoleva, IV; Loshchenov, VB; Shevchik, SA; Kuz'min, SG; Vorozhtsov, GN (November 2007). "[Photodynamic therapy for subretinal neovascular membranes. Communication 1. Results of treatment for age-related macular degeneration]". Vestnik Oftalmologii. 123 (6): 3–7. PMID 18225515.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] ttp://www.photobiology.com/v1/nadezhda/default.htm "Clinical results of updating method of a photodynamic therapy with “Photosens” :use as transport protein human albumines and fractional injection."^{[unreliable source?]}

[2] Apolikhin, Oleg I.; Chernishov, Igor V.; Sivkov, Andrey V.; Altunin, Denis V.; Kuzmin, Sergey G.; Vorozhtsov, Georgy N. (2007). "Adjuvant Photodynamic Therapy (PDT) with Photosensitizer Photosens for Superficial Bladder Cancer. Experimental investigations to treat prostate cancer by PDT with Photosens". Therapeutic Laser Applications and Laser-Tissue Interactions III. pp. 6632_64. doi:10.1364/ECBO.2007.6632_64. ISBN 978-0-8194-6776-8. INIST 19084033.

[3] Sokolov, Victor V.; Chissov, Valery I.; Yakubovskaya, Raisa I.; Aristarkhova, E. I.; Filonenko, E. V.; Belous, T. A.; Vorozhtsov, Georgy N.; Zharkova, Natalia N.; Smirnov, V. V.; Zhitkova, Margarita B. (31 January 1996). Ehrenberg, Benjamin; Jori, Giulio; Moan, Johan (eds.). "Photodynamic therapy (PDT) of malignant tumors by photosensitzer photosens: results of 45 clinical cases". Proceedings of the SPIE. Photochemotherapy: Photodynamic Therapy and Other Modalities. 2625: 281–287. Bibcode:1996SPIE.2625..281S. doi:10.1117/12.230943. S2CID 72304555.

[4] Avetisov, SE; Budzinskaia, MV; Kiseleva, TN; Kazarian, EE; Gurova, IV; Smirnova, TV; Shchegoleva, IV; Loshchenov, VB; Shevchik, SA; Kuz'min, SG; Vorozhtsov, GN (November 2007). "[Photodynamic therapy for subretinal neovascular membranes. Communication 1. Results of treatment for age-related macular degeneration]". Vestnik Oftalmologii. 123 (6): 3–7. PMID 18225515.

[1]

[2]

[3]

[4]